InfaCare Pharmaceutical Corporation
InfaCare and Recordati Complete International Licensing Agreement for Stanate
Published in Law and Health Weekly, July 16th, 2005
InfaCare Pharmaceutical Corporation and Recordati, a pharmaceutical company based in Milan, Italy, jointly announced the signing of an exclusive licensing agreement that provides Recordati the rights to develop and market Stanate (stannsoporfin), a first-in-class agent for the treatment of jaundice in babies, for Europe and for certain territories of Northern Africa and the Middle East. Stanate is in late stage clinical development in the US.
Recordati will continue the development of the drug for their assigned territory. While the specific terms of the agreement were not revealed, it was disclosed that Recordati will make certain milestone payments to InfaCare during...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Albert Schweitzer Hospital, Dordrecht
Prolonged skin staining after intradermal use of patent blue purported - Alnylam Pharmaceuticals, Inc.
RNAi patent granted by the European Patent Office - Australia EpiTan Limited
Endpoint trial of Melanotan begins in Sydney - CytRx Corporation
Commission releases biopharmaceutical company from conflict of interest inquiry - Elan Corp., plc
Neuroscience-based biotech settles legal action with former employee - Enzo Biochem, Inc.
Company acquires rights to orphan drug candidate for uveitis - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
